Observational studyDrug safety2024

The Safety of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: Analyses from a Prospective, Single-Arm, Multicenter, 12-Week Observational Study.

Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.